Allergy Therapeutics

United Kingdom
Worthing, England, United Kingdom, BN14 8SA

Company profile

Allergy Therapeutics company profile

They have provided general information for the allergy sufferer and healthcare professionals about the prevention, diagnosis and treatment of the allergic condition with a special focus on allergy vaccination (also known as specific immunotherapy or desensitisation therapy), the only treatment to deal with the underlying cause and not just the symptoms!

Business identity

Phone number
+4401903844700
Operating status
Active
Company type
For Profit
Employee range
501-1,000 employees
Revenue range
$50,000+
Founded
1934-01-01, Year

Headquarters

Postal code
BN14 8SA
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$102.6M
Last funding
Post IPO Equity / $72.6M / 2025-10-29
Last equity funding
Post IPO Equity / $72.6M
Founders
1
Articles
57
Exited on
2004-10-11

Founders and investors

Founders

Keith Carter